Effect of Pelvic Floor Muscle Training on Balance and Fall Risk in Females With Urinary Incontinence
Launched by CAIRO UNIVERSITY · Dec 13, 2024
Trial Information
Current as of November 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how pelvic floor muscle training can help improve balance and reduce the risk of falls in postmenopausal women who experience urinary incontinence, which is the involuntary loss of urine. The goal is to find out if strengthening these muscles can not only help with urinary issues but also make it safer for these women to move around, ultimately preventing injuries.
To be eligible for this study, participants must be women aged 50 to 60 who are postmenopausal, have a body mass index (BMI) below 30, and are not active (sedentary). They should also be experiencing urinary incontinence and have some balance problems, but they must be able to walk across a small room without help. Women with certain medical conditions, such as severe cognitive issues or neurological diseases, will not be able to participate. If selected, participants can expect to engage in pelvic floor muscle training exercises and be monitored for any changes in their balance and fall risk throughout the trial.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. All females will be postmenopausal. 2. Their ages will range from: 50-60 years. 3. Their BMI will be less than 30 kg\\m2. 4. All females will be suffering from urinary incontinence. 5. All females will be sedentary. 6. All females will have balance disorders. 7.All females will be able to walk across a small room without an assistive device.
- Exclusion Criteria:
- • 1. History of lower extremity injury, surgery or pain during ADL.
- • 2. Females having any vestibular problems, otitis media, labyrinthitis or any inner ear problems that affect balance.
- • 3. Women with mild, moderate and severe cognitive deficits.
- • 4. Women with neurological diseases, including conditions after a Stroke.
- • 5. Females with a history of brain injury.
- • 6. Females with significant visual and hearing damage confirmed by neurological examination.
- • 7. Females with serious internal orthopedic and oncological diseases.
- • -
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, Giza, Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported